Concepts (193)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Out-of-Hospital Cardiac Arrest | 16 | 2024 | 56 | 4.830 |
Why?
|
| Cardiopulmonary Resuscitation | 16 | 2024 | 92 | 3.680 |
Why?
|
| Ventricular Fibrillation | 11 | 2015 | 106 | 2.600 |
Why?
|
| Emergency Medical Services | 11 | 2024 | 266 | 2.390 |
Why?
|
| Heart Arrest | 12 | 2023 | 173 | 1.790 |
Why?
|
| Chest Pain | 4 | 2024 | 84 | 1.510 |
Why?
|
| ST Elevation Myocardial Infarction | 3 | 2024 | 90 | 1.480 |
Why?
|
| Hypothermia, Induced | 3 | 2017 | 40 | 1.330 |
Why?
|
| Swine | 12 | 2015 | 380 | 1.240 |
Why?
|
| Electrocardiography | 6 | 2024 | 554 | 1.160 |
Why?
|
| Resuscitation | 5 | 2017 | 72 | 1.050 |
Why?
|
| Renal Colic | 2 | 2015 | 14 | 0.930 |
Why?
|
| Coronary Circulation | 4 | 2009 | 52 | 0.920 |
Why?
|
| Quality-Adjusted Life Years | 4 | 2023 | 63 | 0.860 |
Why?
|
| Electric Countershock | 4 | 2017 | 102 | 0.840 |
Why?
|
| Acute Coronary Syndrome | 3 | 2023 | 253 | 0.810 |
Why?
|
| Triage | 2 | 2024 | 126 | 0.780 |
Why?
|
| Moon | 1 | 2022 | 1 | 0.780 |
Why?
|
| Models, Animal | 5 | 2015 | 237 | 0.730 |
Why?
|
| Emergency Service, Hospital | 6 | 2024 | 1102 | 0.640 |
Why?
|
| United States | 16 | 2024 | 7855 | 0.590 |
Why?
|
| Prospective Studies | 10 | 2024 | 3301 | 0.580 |
Why?
|
| Disability Evaluation | 1 | 2019 | 217 | 0.550 |
Why?
|
| Cost of Illness | 4 | 2024 | 162 | 0.550 |
Why?
|
| Coma | 1 | 2017 | 13 | 0.540 |
Why?
|
| Registries | 8 | 2024 | 893 | 0.490 |
Why?
|
| Time Factors | 10 | 2024 | 3770 | 0.480 |
Why?
|
| Flank Pain | 1 | 2015 | 8 | 0.480 |
Why?
|
| Ureterolithiasis | 1 | 2015 | 13 | 0.480 |
Why?
|
| Male | 28 | 2024 | 29927 | 0.460 |
Why?
|
| Humans | 38 | 2024 | 63512 | 0.460 |
Why?
|
| Female | 27 | 2024 | 32912 | 0.440 |
Why?
|
| Retrospective Studies | 13 | 2024 | 6670 | 0.440 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 466 | 0.430 |
Why?
|
| Adult | 14 | 2024 | 16837 | 0.430 |
Why?
|
| Decision Support Techniques | 1 | 2015 | 196 | 0.410 |
Why?
|
| Random Allocation | 6 | 2015 | 199 | 0.410 |
Why?
|
| Infusions, Intraosseous | 2 | 2010 | 8 | 0.410 |
Why?
|
| Databases, Factual | 3 | 2021 | 873 | 0.390 |
Why?
|
| Epinephrine | 2 | 2010 | 44 | 0.390 |
Why?
|
| Middle Aged | 15 | 2024 | 17641 | 0.370 |
Why?
|
| Drug Overdose | 2 | 2024 | 131 | 0.370 |
Why?
|
| Quality of Life | 1 | 2019 | 1230 | 0.360 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2015 | 361 | 0.360 |
Why?
|
| Adolescent | 6 | 2023 | 6248 | 0.340 |
Why?
|
| National Institutes of Health (U.S.) | 3 | 2022 | 117 | 0.340 |
Why?
|
| Arteries | 1 | 2010 | 81 | 0.320 |
Why?
|
| Sus scrofa | 1 | 2009 | 30 | 0.320 |
Why?
|
| Infusions, Intravenous | 1 | 2010 | 173 | 0.310 |
Why?
|
| Aged | 13 | 2024 | 14469 | 0.310 |
Why?
|
| Sodium Chloride | 1 | 2009 | 63 | 0.310 |
Why?
|
| Aged, 80 and over | 8 | 2023 | 5471 | 0.300 |
Why?
|
| Adenosine A1 Receptor Antagonists | 1 | 2008 | 5 | 0.290 |
Why?
|
| Xanthines | 1 | 2008 | 8 | 0.290 |
Why?
|
| Ventilators, Negative-Pressure | 1 | 2007 | 1 | 0.270 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 1647 | 0.260 |
Why?
|
| Purinergic P1 Receptor Antagonists | 1 | 2006 | 4 | 0.260 |
Why?
|
| Regional Blood Flow | 1 | 2007 | 112 | 0.260 |
Why?
|
| Heart Arrest, Induced | 1 | 2006 | 13 | 0.260 |
Why?
|
| Animals | 15 | 2015 | 20666 | 0.250 |
Why?
|
| Acetabulum | 1 | 2006 | 3 | 0.250 |
Why?
|
| Epilepsy, Tonic-Clonic | 1 | 2006 | 8 | 0.250 |
Why?
|
| Fractures, Closed | 1 | 2006 | 3 | 0.250 |
Why?
|
| Sensitivity and Specificity | 2 | 2021 | 1147 | 0.240 |
Why?
|
| Pain Measurement | 2 | 2005 | 345 | 0.240 |
Why?
|
| Gastric Mucosa | 1 | 2005 | 53 | 0.230 |
Why?
|
| Syncope | 1 | 2005 | 42 | 0.230 |
Why?
|
| Arteriovenous Malformations | 1 | 2005 | 43 | 0.230 |
Why?
|
| Blood Circulation | 2 | 2014 | 8 | 0.230 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2005 | 79 | 0.220 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 1094 | 0.220 |
Why?
|
| Fractures, Bone | 1 | 2005 | 143 | 0.210 |
Why?
|
| Computers | 1 | 2024 | 49 | 0.210 |
Why?
|
| Aminophylline | 1 | 2003 | 4 | 0.200 |
Why?
|
| Creatine Kinase | 1 | 2003 | 41 | 0.200 |
Why?
|
| Troponin I | 1 | 2003 | 35 | 0.200 |
Why?
|
| Cardiotonic Agents | 1 | 2003 | 53 | 0.200 |
Why?
|
| Isoenzymes | 1 | 2003 | 140 | 0.200 |
Why?
|
| Odds Ratio | 3 | 2020 | 768 | 0.190 |
Why?
|
| Pain | 1 | 2005 | 406 | 0.190 |
Why?
|
| Hospitals, Community | 1 | 2022 | 71 | 0.190 |
Why?
|
| Young Adult | 3 | 2019 | 4700 | 0.190 |
Why?
|
| Myocardial Ischemia | 1 | 2003 | 117 | 0.190 |
Why?
|
| Reproducibility of Results | 2 | 2024 | 1655 | 0.190 |
Why?
|
| Public Health | 1 | 2024 | 187 | 0.190 |
Why?
|
| Trauma Centers | 1 | 2022 | 123 | 0.180 |
Why?
|
| Clinical Protocols | 2 | 2020 | 134 | 0.180 |
Why?
|
| Treatment Outcome | 6 | 2017 | 5699 | 0.180 |
Why?
|
| Bystander Effect | 1 | 2020 | 6 | 0.170 |
Why?
|
| Observer Variation | 1 | 2021 | 214 | 0.170 |
Why?
|
| Infant, Newborn | 3 | 2024 | 1358 | 0.170 |
Why?
|
| Survivors | 1 | 2021 | 171 | 0.160 |
Why?
|
| Cytochromes c | 1 | 2019 | 29 | 0.160 |
Why?
|
| Lactic Acid | 1 | 2019 | 76 | 0.150 |
Why?
|
| Double-Blind Method | 2 | 2015 | 741 | 0.150 |
Why?
|
| Task Performance and Analysis | 1 | 2018 | 129 | 0.140 |
Why?
|
| Risk Factors | 2 | 2019 | 5359 | 0.140 |
Why?
|
| Spermatic Cord Torsion | 2 | 2008 | 13 | 0.140 |
Why?
|
| Logistic Models | 2 | 2020 | 1276 | 0.140 |
Why?
|
| Prognosis | 2 | 2019 | 1749 | 0.140 |
Why?
|
| Body Temperature Regulation | 1 | 2017 | 20 | 0.130 |
Why?
|
| Principal Component Analysis | 1 | 2017 | 61 | 0.130 |
Why?
|
| Neurologic Examination | 1 | 2017 | 53 | 0.130 |
Why?
|
| Research Support as Topic | 1 | 2017 | 42 | 0.130 |
Why?
|
| Unconsciousness | 1 | 2016 | 3 | 0.130 |
Why?
|
| Infant | 2 | 2024 | 1645 | 0.130 |
Why?
|
| Chi-Square Distribution | 1 | 2017 | 418 | 0.130 |
Why?
|
| Feasibility Studies | 3 | 2022 | 572 | 0.120 |
Why?
|
| Clinical Decision-Making | 1 | 2017 | 165 | 0.120 |
Why?
|
| Recovery of Function | 1 | 2017 | 288 | 0.120 |
Why?
|
| Child | 3 | 2023 | 4528 | 0.120 |
Why?
|
| Cardiology | 1 | 2017 | 168 | 0.120 |
Why?
|
| Hospitalization | 2 | 2021 | 1364 | 0.120 |
Why?
|
| Pilot Projects | 3 | 2022 | 1008 | 0.120 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 937 | 0.110 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2015 | 50 | 0.110 |
Why?
|
| Emergency Treatment | 1 | 2015 | 58 | 0.110 |
Why?
|
| Patient Selection | 1 | 2017 | 490 | 0.110 |
Why?
|
| Biomedical Research | 1 | 2017 | 268 | 0.110 |
Why?
|
| Survival Rate | 2 | 2022 | 851 | 0.110 |
Why?
|
| Risk Assessment | 1 | 2021 | 2082 | 0.110 |
Why?
|
| Coronary Thrombosis | 1 | 2014 | 21 | 0.110 |
Why?
|
| Clinical Competence | 1 | 2018 | 727 | 0.100 |
Why?
|
| Time-to-Treatment | 1 | 2014 | 112 | 0.100 |
Why?
|
| Vasoconstrictor Agents | 2 | 2019 | 70 | 0.100 |
Why?
|
| Body Temperature | 2 | 2009 | 45 | 0.100 |
Why?
|
| Hospital Mortality | 1 | 2017 | 878 | 0.100 |
Why?
|
| Disease Models, Animal | 4 | 2014 | 2187 | 0.090 |
Why?
|
| Intubation, Intratracheal | 2 | 2010 | 202 | 0.090 |
Why?
|
| Sex Factors | 1 | 2014 | 978 | 0.090 |
Why?
|
| Blood Gas Analysis | 1 | 2010 | 34 | 0.080 |
Why?
|
| Child, Preschool | 1 | 2016 | 1992 | 0.080 |
Why?
|
| Sympathomimetics | 1 | 2010 | 5 | 0.080 |
Why?
|
| Hospitals | 2 | 2023 | 394 | 0.080 |
Why?
|
| Defibrillators | 1 | 2010 | 16 | 0.080 |
Why?
|
| Cerebrum | 1 | 2010 | 16 | 0.080 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2010 | 73 | 0.080 |
Why?
|
| Stomach | 1 | 2010 | 88 | 0.080 |
Why?
|
| Age Factors | 1 | 2014 | 1561 | 0.080 |
Why?
|
| Cold Temperature | 1 | 2009 | 51 | 0.080 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 215 | 0.080 |
Why?
|
| Needles | 1 | 2009 | 67 | 0.080 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2010 | 458 | 0.080 |
Why?
|
| Thermography | 1 | 2008 | 7 | 0.070 |
Why?
|
| Heart Conduction System | 1 | 2008 | 53 | 0.070 |
Why?
|
| Electric Impedance | 1 | 2008 | 36 | 0.070 |
Why?
|
| Adenosine | 1 | 2008 | 78 | 0.070 |
Why?
|
| Respiration, Artificial | 1 | 2010 | 297 | 0.070 |
Why?
|
| Survival Analysis | 1 | 2008 | 584 | 0.060 |
Why?
|
| Emergency Medical Technicians | 1 | 2006 | 22 | 0.060 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2006 | 42 | 0.060 |
Why?
|
| Sclerotherapy | 1 | 2005 | 9 | 0.060 |
Why?
|
| American Heart Association | 2 | 2021 | 126 | 0.060 |
Why?
|
| Analgesics | 1 | 2005 | 102 | 0.060 |
Why?
|
| Guideline Adherence | 1 | 2006 | 305 | 0.050 |
Why?
|
| Acute Disease | 1 | 2005 | 672 | 0.050 |
Why?
|
| Pain Threshold | 1 | 2003 | 25 | 0.050 |
Why?
|
| Creatine Kinase, MB Form | 1 | 2003 | 9 | 0.050 |
Why?
|
| Intuition | 1 | 2003 | 2 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2007 | 724 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2023 | 2574 | 0.050 |
Why?
|
| Advanced Cardiac Life Support | 1 | 2003 | 14 | 0.050 |
Why?
|
| Observational Studies as Topic | 1 | 2023 | 61 | 0.050 |
Why?
|
| Reference Values | 1 | 2003 | 331 | 0.050 |
Why?
|
| Venous Thrombosis | 1 | 2003 | 115 | 0.050 |
Why?
|
| Exercise Test | 1 | 2003 | 252 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2003 | 268 | 0.040 |
Why?
|
| Inpatients | 1 | 2023 | 305 | 0.040 |
Why?
|
| Referral and Consultation | 1 | 2022 | 422 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2018 | 163 | 0.040 |
Why?
|
| Patient Simulation | 1 | 2018 | 72 | 0.040 |
Why?
|
| Budgets | 1 | 2017 | 7 | 0.030 |
Why?
|
| Financing, Government | 1 | 2017 | 31 | 0.030 |
Why?
|
| Sheep | 2 | 2008 | 179 | 0.030 |
Why?
|
| Cause of Death | 1 | 2017 | 221 | 0.030 |
Why?
|
| Shock, Cardiogenic | 1 | 2014 | 103 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2014 | 498 | 0.020 |
Why?
|
| Echocardiography | 1 | 2014 | 502 | 0.020 |
Why?
|
| Comorbidity | 1 | 2014 | 1120 | 0.020 |
Why?
|
| Tracheotomy | 1 | 2010 | 7 | 0.020 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2014 | 216 | 0.020 |
Why?
|
| Abdominal Wall | 1 | 2010 | 23 | 0.020 |
Why?
|
| Transducers | 1 | 2010 | 26 | 0.020 |
Why?
|
| Pressure | 1 | 2010 | 79 | 0.020 |
Why?
|
| Tracheostomy | 1 | 2010 | 36 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2014 | 540 | 0.020 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2006 | 25 | 0.020 |
Why?
|
| Testis | 1 | 2006 | 149 | 0.010 |
Why?
|
| Oxygen | 1 | 2006 | 317 | 0.010 |
Why?
|
| Ischemia | 1 | 2006 | 205 | 0.010 |
Why?
|
| Probability | 1 | 2003 | 170 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2003 | 485 | 0.010 |
Why?
|
| Prevalence | 1 | 2003 | 1380 | 0.010 |
Why?
|